What this record means
The record shows that VIVENDA is an abandoned application – the owner, Hoffmann‑La Roche Inc., filed an express abandonment on July 8 2001, so the mark is not live or registered. The filing covered only class 005, specifically “pharmaceutical preparation for the treatment of cancer,” so a later use of VIVENDA in that therapeutic area would be the closest record‑based concern. Because the filing was limited to that narrow pharmaceutical description, the record does not give Hoffmann‑La Roche control over every use of the word VIVENDA in other industries. The prosecution history simply notes the usual examiner assignment and a correspondence date before the abandonment, with no indication of a Supplemental Register filing. The latest meaningful event is the express abandonment on July 8 2001, and no enforcement actions appear in the supplied history. I'd treat this as a moderate concern if you plan a cancer‑related drug name, but the risk drops sharply for unrelated goods or services.
Informational only - not legal advice.